Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Virtual nature walks for depression in progressive multiple sclerosis

Official title: Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients

Run by University of Michigan · NCT07392879 · Data updated 2026-11-12

This project tests whether immersive at-home virtual-reality nature walks using the Apple Vision Pro, added to usual care, can reduce depressive symptoms in people with progressive MS.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedFebruary 12, 2026
Trial IDNCT07392879 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with neurologist-confirmed primary or secondary progressive MS who have PROMIS Depression T-scores >55, can consent and use VR at home, and (for some groups) are receiving antidepressant medication or psychotherapy are ideal candidates.

Probably not a fit

People with severe cognitive or visual impairments, marked motion sickness or claustrophobia, active suicidal ideation or other uncontrolled psychiatric conditions, or those enrolled in other depression trials are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study delivers immersive VR nature experiences on the Apple Vision Pro to people with progressive MS and elevated depressive symptoms, comparing VR plus usual care, VR alone, and usual care alone. Participants complete at-home sessions while researchers measure feasibility, acceptability, and changes in depression, stress, anxiety, sleep, insomnia, and fatigue using PROMIS and other patient-reported measures. The trial emphasizes remote deployment and usability testing of a high-resolution consumer headset to overcome mobility barriers common in progressive MS. Outcomes will compare symptom change and adherence across groups to see if combining VR with current therapies provides greater benefit.

Why it matters

Potential benefit: If successful, the intervention could offer an accessible at-home way to reduce depression, stress, and fatigue and improve sleep for people with progressive MS.

How similar studies have gone: Prior VR nature and immersive relaxation studies have shown modest mood and stress improvements in general and some neurological populations, but applying high-resolution headsets like the Apple Vision Pro specifically in progressive MS is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed diagnosis of progressive Multiple Sclerosis (MS, primary or secondary) by a neurologist or an MS center
* Patient-Reported Outcomes Measurement Information System (PROMIS) Depression T-scores \>55 at baseline
* Ability to provide informed consent and participate in VR sessions at home
* For Some Participants (Groups 1 and 2) currently receiving antidepressant or psychotherapy treatments (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), or psychotherapy) for the management of depression

Exclusion Criteria:

* Severe cognitive impairments or visual deficits that may interfere with VR use, including contraindications like agoraphobia, claustrophobia, or motion sickness
* Current participation in other clinical trials targeting depression
* Severe psychiatric conditions that require hospitalization, or suicidal ideation, passive or active, psychosis, or active substance and alcohol abuse (score greater than 1 on CAGE (Cut down, Annoyed, Guilty, Eye-opener) Adapted to Include Drugs (CAGE-AID))
* Another neurological or autoimmune disease per protocol
* Participants that require vision correction, unless that vision correction is mild (± 1), or the participant has prescription contact lenses.

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.